Medical Devices & Surgical Technology Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Devices & Surgical Technology Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Chronic Tinnitus
Agreement signed to develop treatments for inner ear disorders
July 25th, 2004
Durect Corporation (DRRX) and NeuroSystec Corporation, a privately held company located in Valencia, California, announced that they have signed an exclusive agreement to develop, market and sell products for the treatment of certain inner ear disorders, including chronic tinnitus (ringing in the ears). Under the agreement, Durect granted to NeuroSystec exclusive worldwide rights to develop and commercialize products designed for the treatment of tinnitus and to improve post-operative recovery and tolerance of surgical implantation of cochlear devices using specified Durect proprietary drug treatment methods and drug delivery technologies to deliver precise doses of...
Source: Medical Devices & Surgical Technology Week (2004-07-25)
|
